Continuous Vs Intermittent Non Invasive Blood Pressure Monitoring in Preventing Post Operative Organ Failure
Launched by UNIVERSITY OF MESSINA · Aug 10, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether continuous blood pressure monitoring can help prevent problems after surgery, compared to the traditional method of checking blood pressure at intervals. Continuous monitoring means that a device keeps track of your blood pressure all the time during surgery, which might allow doctors to spot and treat blood pressure issues more quickly—possibly reducing the risk of complications after the operation.
To participate in this trial, you need to be an adult (18 years or older) who is scheduled for non-cardiac surgery that will use non-invasive blood pressure monitoring. However, if you have certain conditions such as chronic kidney disease or if your surgery is very short (less than 60 minutes), you may not be eligible. If you join the study, you can expect to have your blood pressure monitored continuously during your surgery, which could help improve your recovery. The trial is currently recruiting participants, and your involvement could contribute to important findings about how to enhance patient care after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All adult (age ≥18 years) patients scheduled for elective non-cardiac surgery in participating centers
- • Surgical case planned with non invasive blood pressure monitoring according to local clinical practice or policies.
- Exclusion Criteria:
- • Missing of preoperative serum creatinine during 30 days prior surgery
- • Preoperative dialysis
- • Chronic kidney disease (eGFR \< 60ml/min Cockcroft-Gault equation)
- • Surgical procedure lasting less than 60 min
- • Planned use of permissive hypotension
- • Urological procedures (including nephrectomy and renal transplantation)
- • Refusal to give informed consent
About University Of Messina
The University of Messina, a prominent research institution located in Sicily, Italy, is dedicated to advancing medical science through innovative clinical trials. Renowned for its commitment to high-quality research and education, the university fosters interdisciplinary collaboration among its faculty and students to address pressing health challenges. With a focus on patient-centered approaches, the University of Messina aims to contribute valuable insights to the medical community, enhancing treatment options and improving health outcomes through rigorous clinical investigations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Messina, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials